Neurocrine Biosciences NBIX Retained Earnings
Retained Earnings at other companies
Other financials
Where this comes from
Reported directly by Neurocrine Biosciences in its filing.
Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.
The official record: Neurocrine Biosciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Neurocrine Biosciences's retained earnings.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Neurocrine Biosciences's retained earnings?
- Neurocrine Biosciences (NBIX) reported retained earnings of $589.6M in Q1 2026.
- How has Neurocrine Biosciences's retained earnings changed year-over-year?
- Neurocrine Biosciences's retained earnings increased by 11224.5% year-over-year, from -$5.3M to $589.6M.
- What is the long-term trend for Neurocrine Biosciences's retained earnings?
- Over 5 years (2020 to 2025), Neurocrine Biosciences's retained earnings has grown at a -9.2% compound annual growth rate (CAGR), from -$725.4M to $447.7M.
- What does retained earnings mean?
- Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.